An Autotaxin/Lysophosphatidic Acid/Interleukin-6 Amplification Loop Drives Scleroderma Fibrosis
Author:
Affiliation:
1. Massachusetts General Hospital and Harvard Medical School; Boston Massachusetts
2. PharmAkea; San Diego California
3. Boston University; Boston Massachusetts
Funder
NIH
Scleroderma Foundation
Scleroderma Research Foundation grant
Publisher
Wiley
Subject
Immunology,Rheumatology,Immunology and Allergy
Reference43 articles.
1. Amelioration of dermal fibrosis by genetic deletion or pharmacologic antagonism of lysophosphatidic acid receptor 1 in a mouse model of scleroderma;Castelino;Arthritis Rheum,2011
2. Production of lysophosphatidic acid in blister fluid: involvement of a lysophospholipase D activity;Mazereeuw-Hautier;J Invest Dermatol,2005
3. Elevated serum levels of arachidonoyl-lysophosphatidic acid and sphingosine 1-phosphate in systemic sclerosis;Tokumura;Int J Med Sci,2009
4. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis;Clements;J Rheumatol,1995
5. The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time;Steen;Arthritis Rheum,1997
Cited by 75 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Screening Ultra-Large Encoded Compound Libraries Leads to Novel Protein–Ligand Interactions and High Selectivity;Journal of Medicinal Chemistry;2024-01-10
2. WTAP boosts lipid oxidation and induces diabetic cardiac fibrosis by enhancing AR methylation;iScience;2023-10
3. Investigational drugs for the treatment of scleroderma: what’s new?;Expert Opinion on Investigational Drugs;2023-07-03
4. Clinical Trials in Systemic Sclerosis: Crossroads and Opportunities;Arthritis & Rheumatology;2023-06-23
5. A 24‐Week, Phase IIa, Randomized, Double‐Blind, Placebo‐Controlled Study of Ziritaxestat in Early Diffuse Cutaneous Systemic Sclerosis;Arthritis & Rheumatology;2023-05-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3